COST UTILITY ANALYSIS OF ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE FOR PATIENTS WITH TYPE 2 DIABETES IN SAUDI ARABIA

被引：0
|
作者：
Hassan, M. [1 ]
Barham, L. [2 ]
机构：
[1] Novo Nordisk, Riyadh 01, Saudi Arabia
[2] Univ South Wales, Learna Ltd Partnership, Royston, Hrt, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE23
引用
下载
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [41] Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes
    Tuchscherer, Rhianna M.
    Thompson, Angela M.
    Trujillo, Jennifer M.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (12) : 1224 - 1232
  • [42] Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials
    Jendle, Johan
    Birkenfeld, Andreas L.
    Polonsky, William H.
    Silver, Robert
    Uusinarkaus, Kari
    Hansen, Thomas
    Hakan-Bloch, Jonas
    Tadayon, Sayeh
    Davies, Melanie J.
    DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2315 - 2326
  • [43] Pharmacokinetics of Once Weekly Dulaglutide in Patients with Type 2 Diabetes Mellitus
    De la Pena, Amparo
    Loghin, Corina
    Cui, Xuewei
    Zhang, Xin
    Geiser, Jeanne S.
    Martin, Jennifer A.
    Chien, Jenny Y.
    DIABETES, 2014, 63 : A251 - A252
  • [44] Low Incidence of Anti-drug Antibody in Type 2 Diabetes Patients Treated with Once-Weekly Dulaglutide
    Milicevic, Zvonko
    Anglin, Greg
    Harper, Kristine
    Konrad, Robert
    Skrivanek, Zachary
    Glaesner, Wolfgang
    Mace, Kenneth
    DIABETES, 2015, 64 : A292 - A292
  • [45] Pharmacokinetics of once weekly dulaglutide in patients with type 2 diabetes mellitus
    de la Pena, A.
    Loghin, C.
    Cui, X.
    Zhang, X.
    Geiser, J. S.
    Martin, J.
    Chien, J. Y.
    DIABETOLOGIA, 2014, 57 : S349 - S349
  • [46] Relationship between Weight Change and Glycemic Control with Once-Weekly Dulaglutide Treatment in Patients with Type 2 Diabetes
    Lando, Laura Fernandez
    Umpierrez, Guillermo E.
    Pantalone, Kevin M.
    Kwan, Anita
    Zimmermann, Alan G.
    DIABETES, 2015, 64 : A291 - A292
  • [47] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 Diabetes
    Takamura, Toshinari
    Miyagawa, Jun-Ichiro
    Odawara, Masato
    Takita, Yasushi
    Iwamoto, Noriyuki
    Imaoka, Takeshi
    DIABETES, 2015, 64 : A285 - A285
  • [48] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Yukiko Onishi
    Hitoshi Ishii
    Tomonori Oura
    Masakazu Takeuchi
    Diabetes Therapy, 2020, 11 : 735 - 745
  • [49] Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors
    Zhou, Yan
    Zhu, Jiankun
    Wu, Haiya
    Deng, Yuying
    Ji, Qiuhe
    DIABETES THERAPY, 2021, 12 (10) : 2677 - 2690
  • [50] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Onishi, Yukiko
    Ishii, Hitoshi
    Oura, Tomonori
    Takeuchi, Masakazu
    DIABETES THERAPY, 2020, 11 (03) : 735 - 745
12345